ClinicalTrials.gg
CompletedNCT07470190Updated Nov 17, 2026

Anatomical Evaluation of Supraspinatus Through Ultrasonography and Biomechanical Measurements Following Different Combinations of Physical Therapies in Patients of Supraspinatus Tendinitis

An interventional study of Blood flow Restriction therapy and ESWT in Supraspinatus Tendinitis, sponsored by Sehat Medical Complex. Completed at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Sehat Medical Complex · Not applicable, Interventional, and Treatment

How we know

Updated Nov 17, 2026Now CompletedNow Active, not recruiting+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Tendinopathy with a site in Pakistan — 1 open to participants now, 3 under way, none of them phase 3. Tendinopathy · Pakistan.

Enrollment
2nd of 11
60 · median 38
Started
2026
with 1 other
No phase
11 of 12
1 open now
Registered
8th of 12
by date
Lead sponsor
2 of 12
Sehat Medical Complex

Among the 12 studies in Tendinopathy with a site in Pakistan, this one is the 2nd largest by enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2026, is one of 11 with no phase, and was the 8th registered.

Tendinopathy

399 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.

Browse Tendinopathy studies →

Open to participants now

1 of the 12 studies in Tendinopathy with a site in Pakistan is open now. Recruiting first, the newest first:

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 46 Tendinopathy studies recruiting now, 17 (37%) set no upper age limit and 22 (48%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.

This study: 40 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Tendinopathy with a site in Pakistan, or all of them as a file.
02

Study summary

A randomized controlled trial will be conducted to get the expected outcomes. Patients of both gender groups with unilateral shoulder pain will be selected with age range 40-60 years from Sehat medical complex and randomly allocated into four groups (Group A, B, C and D) of two different trials (Trial I and Trial II). The sample size will be 120 patients for both trials. Musculoskeletal ultrasound, goniometry, pain pressure threshold, dynamometer and functional indices will be used to measure the tendon thickness, range of motion, pain, muscle strength and function level. The group A will get BFRT, Group B will get ESWT, group c will get the combination of both and group D will be the Control group (Routine physical therapy). In Trial II the group A will get BFRT, Group B will get Eccentric Training, Group C will get combination of both A \& B and group D will be control group. data will be collected at baseline, 4th week, 8th week and 12 week of interventions. For data analysis SPSS version 25 will be used. Repeated measures ANOVA will be applied to compare the quantitative data within and between the groups. Post-Hoc test Tukey and Bonferroni correction will be used. The level of significance will be set at 5% (P\<0.05).

Read the detailed description

Musculoskeletal (MSK) disorders affect 1.71 billion people globally. In Pakistan 3.7-20% people are suffering from shoulder pain and while other rotator cuff muscles have been targeted with various therapies singly, neither supraspinatus tendinitis has received its due attention nor has the effect of combination of therapies been explored on it. Additionally, using the technique of MSK ultrasound will give us an objective quantitative basis for the anatomical evaluation. The tendon dimensions and biomechanical measurements of the supraspinatus show marked and differential improvement under the influence of different combinations of physical therapies compared to any single therapy.

Objectives:

03

Conditions studied

  • Supraspinatus Tendinitis

Browse trials for

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • unilateral shoulder pain
  • both gender group
  • two positive tests of (Neer impingement test, Hawkins-Kendy test, Empty can test),
  • shoulder pain history up to 3 months
  • not receiving any physiotherapy last 3 months.
  • not receiving pain medications (NSAIDS) for last 15 days.

Exclusion criteria

Exclusion Criteria:

  • referred shoulder pain
  • limited shoulder ROM less then 90 degree
  • previous shoulder surgery, intra articular injection or nerve block last 6 months.
  • patient with 180 mmHg blood pressure/uncontrolled BP
  • upper limb fracture, uncontrolled diabetes, open wounds, fistula and vascular surgery.
  • pregnant woman or 6 month history of pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Group A (Blood Flow Restriction Therapy)

    4 Sets of exercise with restriction cuff 30,15,15,15 with cable system pulley

    Other: Blood flow Restriction therapy

  • Experimental
    Group B (Extracorporeal Shock wave therapy)

    10 minutes shocks of 2000 J/session

    Device: ESWT

  • Experimental
    Group C (Combination of BFRT+ESWT)

    Interventional study group Combination therapy

    Other: Blood flow Restriction therapy · Device: ESWT

  • Sham comparator
    Control Group D

    Control group with routine physical therapy

    Other: Control

Interventions

  • OtherBlood flow Restriction therapy

    BFRT 4 Sets of exercise with restriction cuff 30,15,15,15 with cable system pulley ESWT 10 minutes shocks of 2000 J/session

    Also known as: BFRT, ESWT

  • DeviceESWT

    10 minutes shocks of 2000 J/session

    Also known as: Shock wave therapy

  • OtherControl

    Electric heating pad (Besmed, Taiwan) 10 minutes, TENS (Comfy Stim, Taiwan Model #: EV-806) 10 minutes

    Also known as: Routine physical therapy

06

What researchers measure

Primary outcomes

  1. Shoulder Joint Range of Motion from 0-180 degree

    shoulder joint ROM will be measured by Goniometer having 360 degree or inclinometer

    Time frame: 12 weeks

  2. MSK Ultrasound for shoulder

    tendon thickness in long (mm) and short axis (mm)

    Time frame: 12 weeks

  3. Shoulder Functional scale

    Quick-DASH (Quick-Disability of arm shoulder and hand) functional scale, it is 11 items scale with response range 0-5 on. 0 is no disability and 100 shows severe disability. The scale have 5 response options much worse, somewhat worse, unchanged, somewhat better, much better

    Time frame: 12 weeks

  4. Shoulder Joint PAIN

    NPRS 0-10 , 10 is the worse imaginable pain and 0 is no pain

    Time frame: 12 WEEKS

  5. Shoulder Muscle Strength

    Manual muscle testing and Dynamometer

    Time frame: 12 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Lambert B, Hedt C, Daum J, Taft C, Chaliki K, Epner E, McCulloch P. Blood Flow Restriction Training for the Shoulder: A Case for Proximal Benefit. Am J Sports Med. 2021 Aug;49(10):2716-2728. doi: 10.1177/03635465211017524. Epub 2021 Jun 10. PubMed 34110960 ↗
  • Yoshiura K, Stamatakis HC, Welander U, McDavid WD, Shi XQ, Ban S, Kawazu T, Tatsumi M, Kanda S. Physical evaluation of a system for direct digital intra-oral radiography based on a charge-coupled device. Dentomaxillofac Radiol. 1999 Sep;28(5):277-83. doi: 10.1038/sj/dmfr/4600457. PubMed 10490745 ↗
  • Kara D, Ozcakar L, Demirci S, Huri G, Duzgun I. Blood Flow Restriction Training in Patients With Rotator Cuff Tendinopathy: A Randomized, Assessor-Blinded, Controlled Trial. Clin J Sport Med. 2024 Jan 1;34(1):10-16. doi: 10.1097/JSM.0000000000001191. Epub 2023 Sep 14. PubMed 37706671 ↗
  • Jones JW, McCullough LB. Consent for an intraoperative video record. J Vasc Surg. 2001 Dec;34(6):1133-4. doi: 10.1067/mva.2001.119949. No abstract available. PubMed 11743574 ↗
  • Ackmann T, Schneider KN, Schorn D, Rickert C, Gosheger G, Liem D. Comparison of efficacy of supraspinatus tendon tears diagnostic tests: a prospective study on the "full-can," the "empty-can," and the "Whipple" tests. Musculoskelet Surg. 2021 Aug;105(2):149-153. doi: 10.1007/s12306-019-00631-0. Epub 2019 Nov 5. PubMed 31691179 ↗
  • Harrer J, Lonsky V, Dominik J, Zacek P, Sistek J, Harrerova L, Knap J. [Coronary revascularization in diffuse atherosclerosis of the anterior descending coronary artery]. Rozhl Chir. 1997 Jul;76(7):342-8. Czech. PubMed 9446250 ↗
  • Dube MO, Ingwersen KG, Roy JS, Desmeules F, Lewis J, Juul-Kristensen B, Vobbe J, Jensen SL, McCreesh K. Do therapeutic exercises impact supraspinatus tendon thickness? Secondary analyses of the combined dataset from two randomized controlled trials in patients with rotator cuff-related shoulder pain. J Shoulder Elbow Surg. 2024 Sep;33(9):1918-1927. doi: 10.1016/j.jse.2024.03.055. Epub 2024 May 16. PubMed 38762149 ↗
  • Chew E, Lee Day A, Nazarian LN, Kohler M. Basic Musculoskeletal Ultrasound. Med Clin North Am. 2025 Jan;109(1):137-161. doi: 10.1016/j.mcna.2024.06.007. Epub 2024 Aug 3. PubMed 39567090 ↗
  • De Misa RF, Azana JM, Bellas C, Perez B, Rocamora A, Ledo A. Mycosis fungoides with signet-ring cells and monoclonal gammopathy. Int J Dermatol. 1994 Sep;33(9):652-3. doi: 10.1111/j.1365-4362.1994.tb02930.x. No abstract available. PubMed 8002167 ↗
  • Shulman CE, Marshall T, Dorman EK, Bulmer JN, Cutts F, Peshu N, Marsh K. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health. 2001 Oct;6(10):770-8. doi: 10.1046/j.1365-3156.2001.00786.x. PubMed 11679125 ↗
  • Mini E, Grassi F, Cherubino P, Nobili S, Periti P. Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery. J Chemother. 2001 Nov;13 Spec No 1(1):73-9. doi: 10.1179/joc.2001.13.Supplement-2.73. PubMed 11936384 ↗
  • Skimming JW, Banner MJ, Spalding HK, Jaeger MJ, Burchfield DJ, Davenport PW. Nitric oxide inhalation increases alveolar gas exchange by decreasing deadspace volume. Crit Care Med. 2001 Jun;29(6):1195-200. doi: 10.1097/00003246-200106000-00022. PubMed 11395602 ↗
  • Matsunaga H, Iida T, Fukushima T, Santa T, Homma H, Imai K. Boron trifluoride-etherate (Lewis acid) as an efficient acid at cyclization/cleavage reaction of D/L-amino acids affording the retention of their original configuration in the Edman sequencing method of peptides. Biomed Chromatogr. 1996 Mar-Apr;10(2):95-6. doi: 10.1002/(SICI)1099-0801(199603)10:23.0.CO;2-H. PubMed 8924735 ↗
  • Gagnon F, Dagenais GR, Robitaille NM, Lupien PJ. Impact of systolic and diastolic blood pressure on ischemic vascular diseases in French-Canadian men from 1974 to 1990. Can J Cardiol. 1994 Jan-Feb;10(1):97-105. PubMed 8111677 ↗
  • Adler RS. Musculoskeletal ultrasound: a technical and historical perspective. J Ultrason. 2023 Nov 23;23(95):e172-e187. doi: 10.15557/jou.2023.0027. eCollection 2023 Oct. PubMed 38020513 ↗
  • Abdul-Karim S, Abdul-Hamid MS, Ho CA, Ling J. Validity, Reliability and Responsiveness of the Malay Shoulder Pain and Disability Index (M-SPADI) for Patients with Shoulder Pain. Malays Orthop J. 2023 Mar;17(1):160-171. doi: 10.5704/MOJ.2303.019. PubMed 37064621 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — the study protocol

Supporting information: Study protocol

Time frame: 12 weeks till the trail is recutting

Access criteria: by email, any researcher

Data sharing details ↗ · uvas.edu.pk

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in Nov 2026, 8 months.

Of 174 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 38. This study's 8 months is below that.

Counting every sponsor, half of 183 studies reached it within 20 months; a quarter within 7 and three quarters within 37.

Primary completion moved twice since we started tracking on Sep 25, 2026: Aug 2026 → Nov 2026, last on Nov 17, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Aug 2026 → Nov 2026, last on Nov 17, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2026
First posted
Mar 13, 2026
StartActual
Feb 23, 2026
Primary completionActual
Nov 16, 2026was Aug 2026
CompletionActual
Nov 16, 2026was Aug 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting→Completed
changed Oct 1, 2026 · changed Nov 17, 2026
Primary completion
Aug 23, 2026→Nov 16, 2026 (actual)
moved 2 times, Oct 1, 2026 – Nov 17, 2026
Study completion
Aug 30, 2026→Nov 16, 2026 (actual)
moved 2 times, Oct 1, 2026 – Nov 17, 2026
Show all 2 updates
  1. Nov 17, 2026
    Active, not recruiting→Completed
    Primary completion Oct 10, 2026→Nov 16, 2026 (now actual)
    Study completion Oct 30, 2026→Nov 16, 2026 (now actual)
    + 1 other change: verification date
  2. Oct 1, 2026
    Recruiting→Active, not recruiting
    Primary completion Aug 23, 2026→Oct 10, 2026
    Study completion Aug 30, 2026→Oct 30, 2026
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07470190
Lead sponsor
Sehat Medical Complex
Responsible party
Sponsor
First posted
Mar 13, 2026
Start date
Feb 23, 2026
Primary completion
Nov 16, 2026
Completion
Nov 16, 2026
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion